Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Philippe Duchateau , André Choulika , Laurent Poirot

ABSTRACT

The present invention relates to methods of developing genetically engineered, preferably non-alloreactive T-cells for immunotherapy. This method involves the use of RNA-guided endonucleases, in particular Cas9/CRISPR system, to specifically target a selection of key genes in T-cells. The engineered T-cells are also intended to express chimeric antigen receptors (CAR) to redirect their immune activity towards malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies using T-Cells for treating cancer and viral infections. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Philippe Duchateau", 
        "type": "Person"
      }, 
      {
        "name": "Andr\u00e9 Choulika", 
        "type": "Person"
      }, 
      {
        "name": "Laurent Poirot", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3390/v5112748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001463223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2012-01-405365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001745406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nmeth.2649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008703730", 
          "https://doi.org/10.1038/nmeth.2649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2013.04.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013935649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1232033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022072971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tibtech.2013.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031527623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jgg.2013.03.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031629107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ymthe.2005.07.688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038735299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt.2507", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041881936", 
          "https://doi.org/10.1038/nbt.2507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-01-043737", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045180555"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2013.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045630180", 
          "https://doi.org/10.1038/nrclinonc.2013.46"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

The present invention relates to methods of developing genetically engineered, preferably non-alloreactive T-cells for immunotherapy. This method involves the use of RNA-guided endonucleases, in particular Cas9/CRISPR system, to specifically target a selection of key genes in T-cells. The engineered T-cells are also intended to express chimeric antigen receptors (CAR) to redirect their immune activity towards malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies using T-Cells for treating cancer and viral infections.

", "id": "sg:patent.US-9855297-B2", "keywords": [ "method", "T cell", "immunotherapy", "nuclease", "invention", "alloreactive T cell", "endonuclease", "target", "selection", "key gene", "T lymphocyte", "engineered T cell", "chimeric antigen receptor", "redirect", "immune activity", "infected cell", "adoptive immunotherapy", "Neoplasm", "viral infection" ], "name": "Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.433267.7", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-9855297-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:35", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_b670b59c.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-9855297-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-9855297-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-9855297-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-9855297-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

84 TRIPLES      14 PREDICATES      43 URIs      26 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-9855297-B2 schema:about anzsrc-for:3103
2 schema:author N7da81b44a5ad44a6af78a97654f5be3c
3 schema:citation sg:pub.10.1038/nbt.2507
4 sg:pub.10.1038/nmeth.2649
5 sg:pub.10.1038/nrclinonc.2013.46
6 https://doi.org/10.1016/j.cell.2013.04.025
7 https://doi.org/10.1016/j.jgg.2013.03.013
8 https://doi.org/10.1016/j.tibtech.2013.04.004
9 https://doi.org/10.1016/j.ymthe.2005.07.688
10 https://doi.org/10.1126/science.1232033
11 https://doi.org/10.1182/blood-2010-01-043737
12 https://doi.org/10.1182/blood-2012-01-405365
13 https://doi.org/10.3390/v5112748
14 schema:description <p id="p-0001" num="0000">The present invention relates to methods of developing genetically engineered, preferably non-alloreactive T-cells for immunotherapy. This method involves the use of RNA-guided endonucleases, in particular Cas9/CRISPR system, to specifically target a selection of key genes in T-cells. The engineered T-cells are also intended to express chimeric antigen receptors (CAR) to redirect their immune activity towards malignant or infected cells. The invention opens the way to standard and affordable adoptive immunotherapy strategies using T-Cells for treating cancer and viral infections.</p>
15 schema:keywords Neoplasm
16 T cell
17 T lymphocyte
18 adoptive immunotherapy
19 alloreactive T cell
20 chimeric antigen receptor
21 endonuclease
22 engineered T cell
23 immune activity
24 immunotherapy
25 infected cell
26 invention
27 key gene
28 method
29 nuclease
30 redirect
31 selection
32 target
33 viral infection
34 schema:name Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
35 schema:recipient https://www.grid.ac/institutes/grid.433267.7
36 schema:sameAs https://app.dimensions.ai/details/patent/US-9855297-B2
37 schema:sdDatePublished 2019-03-07T15:35
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N4bbcc3ebd7ab443ca279c09ce7f038b7
40 sgo:license sg:explorer/license/
41 sgo:sdDataset patents
42 rdf:type sgo:Patent
43 N0f57f9fb76ce46499a8a9c9ef7ecb70c schema:name André Choulika
44 rdf:type schema:Person
45 N294e2d36b90345dd92627048c654fc52 rdf:first Nb4973f74326645429033ba24102eae9e
46 rdf:rest rdf:nil
47 N2d7ee179d7bf4cb3b53dfe8d6bde6d8d schema:name Philippe Duchateau
48 rdf:type schema:Person
49 N4bbcc3ebd7ab443ca279c09ce7f038b7 schema:name Springer Nature - SN SciGraph project
50 rdf:type schema:Organization
51 N7da81b44a5ad44a6af78a97654f5be3c rdf:first N2d7ee179d7bf4cb3b53dfe8d6bde6d8d
52 rdf:rest Nd9437bcda3eb4f1e8f00c1724f2d403b
53 Nb4973f74326645429033ba24102eae9e schema:name Laurent Poirot
54 rdf:type schema:Person
55 Nd9437bcda3eb4f1e8f00c1724f2d403b rdf:first N0f57f9fb76ce46499a8a9c9ef7ecb70c
56 rdf:rest N294e2d36b90345dd92627048c654fc52
57 anzsrc-for:3103 schema:inDefinedTermSet anzsrc-for:
58 rdf:type schema:DefinedTerm
59 sg:pub.10.1038/nbt.2507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041881936
60 https://doi.org/10.1038/nbt.2507
61 rdf:type schema:CreativeWork
62 sg:pub.10.1038/nmeth.2649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008703730
63 https://doi.org/10.1038/nmeth.2649
64 rdf:type schema:CreativeWork
65 sg:pub.10.1038/nrclinonc.2013.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045630180
66 https://doi.org/10.1038/nrclinonc.2013.46
67 rdf:type schema:CreativeWork
68 https://doi.org/10.1016/j.cell.2013.04.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013935649
69 rdf:type schema:CreativeWork
70 https://doi.org/10.1016/j.jgg.2013.03.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031629107
71 rdf:type schema:CreativeWork
72 https://doi.org/10.1016/j.tibtech.2013.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031527623
73 rdf:type schema:CreativeWork
74 https://doi.org/10.1016/j.ymthe.2005.07.688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038735299
75 rdf:type schema:CreativeWork
76 https://doi.org/10.1126/science.1232033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022072971
77 rdf:type schema:CreativeWork
78 https://doi.org/10.1182/blood-2010-01-043737 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045180555
79 rdf:type schema:CreativeWork
80 https://doi.org/10.1182/blood-2012-01-405365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001745406
81 rdf:type schema:CreativeWork
82 https://doi.org/10.3390/v5112748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001463223
83 rdf:type schema:CreativeWork
84 https://www.grid.ac/institutes/grid.433267.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...